Skip to search formSkip to main contentSkip to account menu

Reyataz

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Un dels principals motius que ens va impulsar en l’eleccio del tema es que es tracta d’untema que pot despertar curiositat entre… 
2009
2009
AVos Life sciences has analysed the revenue contribution of organically developed, licensed or co-developed, acquired and joint… 
2004
2004
The combination has been found to reduce blood levels of the antiretroviral to about a quarter of what they should be. 
2003
2003
Atazanavir (Reyataz) is a protease inhibitor that received FDA approval in June 2003. Other approved drugs in this class include… 
2003
2003
Reyataz, protease inhibitor, is to be used in combination with other antiretroviral agents for the treatment of patients with HIV…